Results 1 to 10 of about 387,314 (311)
Inmunohistochemical detection of pandemic SARSCoV- 2 antigens in lung tissue
The COVID-19 pandemic caused by the SARS-CoV-2 virus has generated globally more than 110.7 million infections and 2.4 million deaths. The severity of this infection can range from asymptomatic, mild to severe.
Jorge Alonso Rivera +5 more
doaj +1 more source
Background The host’s immune system develops in equilibrium with both cellular self-antigens and non-self-antigens derived from microorganisms which enter the body during lifetime. In addition, during the years, a tumor may arise presenting to the immune
Luigi Buonaguro +11 more
doaj +1 more source
Significance of confirming Epstein-Barr virus nuclear antibody as tumor marker [PDF]
Backgrounnd/Aim. Study of the association between Epstein-Barr virus (EBV) and the tumors of the nasopharynx renders an opportunity to introduce causal treatment.
Stošić-Divjak Svetlana +5 more
doaj +1 more source
Recombinant Antigens in Viral Diagnosis [PDF]
DNA-fragments coding for a variety of different viral antigens have been cloned and expressed in E. coli. Selected purified recombinant antigens were used for detection of specific antibodies by the means of ELISA technique. This approach has been used for the development of four different ELISAs for the detection of HIV- and EBV-specific antibodies.
Vornhagen, R. +7 more
openaire +4 more sources
Increasing evidence suggests that post-translational peptide splicing can play a role in the immune response under pathological conditions. This seems to be particularly relevant in Type 1 Diabetes (T1D) since post-translationally spliced epitopes ...
Michele Mishto +5 more
doaj +1 more source
HNSCC: Tumour Antigens and Their Targeting by Immunotherapy
Head and neck squamous cell carcinomas (HNSCC) are a heterogeneous group of malignant tumours typically caused by alcohol and tobacco consumption, although an increasing number of HNSCC arise due to persistent infection with high-risk human papilloma ...
Adrian von Witzleben +4 more
doaj +1 more source
B-Cell Memory Responses to Variant Viral Antigens
A central feature of vertebrate immune systems is the ability to form antigen-specific immune memory in response to microbial challenge and so provide protection against future infection.
Harry N White
doaj +1 more source
Oncogenic viral antigens for engineered T cell immunotherapy: Challenges and opportunities
Viruses that cause malignancies such as hepatocellular carcinoma and cervical cancer are the cause of approximately 20% of all human cancers. In recent years, engineered T cell immunotherapy targeting tumor‐associated antigens (TAAs) has had some success
Haipeng Zhang +5 more
doaj +1 more source
The gastrointestinal tract can be heavily infected by SARS-CoV-2. Being an auto-immunogenic virus, SARS-CoV-2 represents an environmental factor that might play a role in gut-associated autoimmune diseases.
Aaron Lerner +2 more
doaj +1 more source
Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics
Summary: The human leukocyte antigen (HLA)-bound viral antigens serve as an immunological signature that can be selectively recognized by T cells. As viruses evolve by acquiring mutations, it is essential to identify a range of presented viral antigens ...
Adi Nagler +18 more
doaj +1 more source

